Conduit Pharmaceuticals Inc.
CDT
$0.6201
-$0.16-20.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1,082.04% | -315.51% | -155.60% | -112.44% | 107.98% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 90.27% | 167.11% | 264.03% | 256.12% | -239.41% |
| Change in Net Operating Assets | 10.06% | 2,333.33% | -22.95% | 70.83% | -641.33% |
| Cash from Operations | 20.61% | -281.49% | -253.50% | -19.71% | -445.80% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -82.90% | 104.48% | -152.97% | -- | 1,020.37% |
| Cash from Investing | -82.90% | 43.28% | -155.45% | -- | 1,020.37% |
| Total Debt Issued | 400.81% | 218.07% | -- | -- | -216.82% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -99.34% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 41.25% | -- | -- | -- | -- |
| Cash from Financing | 1,116.91% | -80.86% | 927.27% | -- | -144.37% |
| Foreign Exchange rate Adjustments | -99.67% | 200.00% | -120.00% | -2,800.00% | 30,300.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.94% | -101.71% | -20,212.50% | -29,900.00% | -- |